文献速递血液净化与透析水电解质与酸碱

透析监测研究主要结局:血液透析患者临床显著心律失常常见且与透析周期相关

Primary outcomes of the Monitoring in Dialysis Study indicate that clinically significant arrhythmias are common in hemodialysis patients and related to dialytic cycle.
PubMed 文献 · Kidney Int · 2018-02-12

临床显著心律失常发生率在每周首次透析时最高,且在每个透析间期最后12小时升高,尤其长间期。透析前血钠较高和透析液钙超过2.5 mEq/L与临床显著心律失常独立相关。

要点

  • 血液透析患者临床显著心律失常常见,以心动过缓和停搏为主。
  • 心律失常发生率在每周首次透析和透析间期最后12小时升高。
  • 透析前血钠较高和透析液钙超过2.5 mEq/L与临床显著心律失常独立相关。

核心结论

  • 血液透析患者临床显著心律失常常见,心动过缓和停搏而非室性心动过速可能是猝死关键原因。
  • 心律失常与透析周期的时间模式相关,提示调整透析实践可能降低猝死发生率。

研究设计与样本

  • 研究使用植入式循环记录仪对血液透析患者进行6个月连续心律监测。
  • 使用负二项回归模型评估临床显著心律失常的相关因素。

主要发现

  • 44例患者共记录1678次事件,其中大多数为心动过缓(1461次),停搏14次,持续性室性心动过速仅1次。
  • 心房颤动虽未定义为临床显著心律失常,但在41%患者中检出。
  • 每周三次透析时,心律失常发生率在每周首次透析时最高,且在每个透析间期最后12小时升高,尤其长间期。
  • 透析前血清钠较高和透析液钙超过2.5 mEq/L与临床显著心律失常独立相关。

临床怎么用

  • 对血液透析患者应关注心动过缓和停搏,而非仅关注室性心动过速。
  • 考虑调整透析液钙浓度和透析前血钠水平可能有助于降低心律失常风险。
  • 关注每周首次透析和透析间期最后12小时的心律监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Sudden death is one of the more frequent causes of death for hemodialysis patients, but the underlying mechanisms, contribution of arrhythmia, and associations with serum chemistries or the dialysis procedure are incompletely understood. To study this, implantable loop recorders were utilized for continuous cardiac rhythm monitoring to detect clinically significant arrhythmias including sustained ventricular tachycardia, bradycardia, asystole, or symptomatic arrhythmias in hemodialysis patients over six months. Serum chemistries were tested pre- and post-dialysis at least weekly. Dialysis procedure data were collected at every session. Associations with clinically significant arrhythmias were assessed using negative binomial regression modeling. Sixty-six patients were implanted and 1678 events were recorded in 44 patients. The majority were bradycardias (1461), with 14 episodes of asystole and only one of sustained ventricular tachycardia. Atrial fibrillation, although not defined as clinically significant arrhythmias, was detected in 41% of patients. With thrice-weekly dialysis, the rate was highest during the first dialysis session of the week and was increased during the last 12 hours of each inter-dialytic interval, particularly the long interval. Among serum and dialytic parameters, only higher pre-dialysis serum sodium and dialysate calcium over 2.5 mEq/L were independently associated with clinically significant arrhythmias. Thus, clinically significant arrhythmias are common in hemodialysis patients, and bradycardia and asystole rather than ventricular tachycardia may be key causes of sudden death in hemodialysis patients. Associations with the temporal pattern of dialysis suggest that modification of current dialysis practices could reduce the incidence of sudden death.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Roy-Chaudhury P, Tumlin JA, Koplan BA, et al. Primary outcomes of the Monitoring in Dialysis Study indicate that clinically significant arrhythmias are common in hemodialysis patients and related to dialytic cycle. Kidney Int. 2018. PMID: 29395340. doi:10.1016/j.kint.2017.11.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。